Phase I study of the anti-heparin-binding epidermal growth factor-like growth factor antibody U3-1565 with cetuximab in patients with cetuximab- or panitumumab-resistant metastatic colorectal cancer.
Invest New Drugs
; 38(2): 410-418, 2020 04.
Article
in En
| MEDLINE
| ID: mdl-31020609
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Colorectal Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Antibodies, Monoclonal, Humanized
/
Heparin-binding EGF-like Growth Factor
/
Cetuximab
/
Antineoplastic Agents, Immunological
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Invest New Drugs
Year:
2020
Type:
Article
Affiliation country:
Japan